Annual report
3762.TEDINET S100W658
Period2024-04-01 → 2025-03-31
Filed2025-06-27
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 167
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥64.9bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥53.3bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥46.0bn | 2022-04-01 → 2023-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥36.5bn | 2021-04-01 → 2022-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥30.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥30.9bn | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥6.7bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥5.9bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Ordinary income | ¥3.7bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥6.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥5.9bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥5.1bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥3.7bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥3.4bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥4.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.0bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥2.4bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥2.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥4.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥4.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥105.4bn | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥85.8bn | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥65.7bn | at 2023-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥52.5bn | at 2022-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥36.6bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥40.0bn | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥75.4bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥58.7bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥30.0bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥27.0bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥23.9bn | at 2023-03-31v | Cons. | Equity IFRS |
| Net assets / equity | ¥16.3bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Equity (owners) | ¥24.2bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥21.7bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥19.0bn | at 2023-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥17.0bn | at 2022-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥14.8bn | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥27.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥27.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥20.1bn | at 2023-03-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥18.2bn | at 2022-03-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥14.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥14.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥6.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥9.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥6.3bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥5.3bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥2.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.5bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥6.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥1.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥3.1bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥196m | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥911m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥841m | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥799m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥148m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥2.0bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥101.12 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥88.35 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥73.91 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥59.65 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥58.9 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥57.92 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥100.81 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥88.03 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥73.67 | 2022-04-01 → 2023-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥59.46 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥58.73 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥57.75 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥602.64 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥541.87 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥475.24 | at 2023-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥426.4 | at 2022-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥372.96 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥373.53 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 23.0% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 25.4% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 28.9% | at 2023-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 32.4% | at 2022-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.5% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.1% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 17.7% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 17.4% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 16.4% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 14.9% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 16.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.5% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 1,073 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥46.3bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥37.0bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥30.9bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥26.5bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥23.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥4.9bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥3.8bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥5.0bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥3.8bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.7bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.7bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.3bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.0bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥2.7bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥2.4bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.7bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥82.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥65.0bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥47.5bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥37.0bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥29.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥64.3bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥48.7bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥18.1bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥16.3bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥14.2bn | at 2023-03-31v | Standalone | Net assets |
| Net assets / equity | ¥12.6bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥11.4bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥15.7bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥16.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥75.29 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.16 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.2 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.76 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.17 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥75.07 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥67.91 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥60 | 2022-04-01 → 2023-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.62 | 2021-04-01 → 2022-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥47.04 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥34 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥23 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥447.12 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥401.4 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥352.02 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥312.64 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥283.36 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 21.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.8% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.6% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 17.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.1% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.1% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.7% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 44,518,400 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,518,400 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,518,400 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,518,400 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,518,400 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 619 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 553 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 544 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 511 | at 2022-03-31v | Standalone | Number of employees |
| Employees | 475 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥499m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥499m |
| Application Servicereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥9.5bn |
| Application Servicereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥9.2bn |
| Application Servicereportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥275m |
| Application Servicereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥142m |
| Information Infrastructurereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥45.8bn |
| Information Infrastructurereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥45.6bn |
| Information Infrastructurereportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥224m |
| Information Infrastructurereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥5.3bn |
| Medical System Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥10.1bn |
| Medical System Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥10.1bn |
| Medical System Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥65.4bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥64.9bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥499m |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥6.7bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥466m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥466m |
| Application Servicereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥8.5bn |
| Application Servicereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥8.2bn |
| Application Servicereportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥265m |
| Application Servicereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥317m |
| Information Infrastructurereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥35.2bn |
| Information Infrastructurereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥35.0bn |
| Information Infrastructurereportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥201m |
| Information Infrastructurereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥4.0bn |
| Medical System Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥10.1bn |
| Medical System Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥10.1bn |
| Medical System Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥53.8bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥53.3bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥466m |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥5.9bn |
| Application Servicereportable segment | employees | at 2025-03-31 | 301 pure |
| Information Infrastructurereportable segment | employees | at 2025-03-31 | 253 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,877
| Item | Context | Value | Unit |
|---|---|---|---|
| Government grant income IFRS | Prior1YearDuration | 2246000 | JPY |
| Government grant income IFRS | CurrentYearDuration | 6758000 | JPY |
| Gain on sale of fixed assets IFRS | Prior1YearDuration | 2558000 | JPY |
| Gain on sale of fixed assets IFRS | CurrentYearDuration | 5922000 | JPY |
| Other other income IFRS | Prior1YearDuration | 10250000 | JPY |
| Other other income IFRS | CurrentYearDuration | 16129000 | JPY |
| Other income IFRS | Prior1YearDuration | 24071000 | JPY |
| Other income IFRS | CurrentYearDuration | 38156000 | JPY |
| Loss on sale and retirement of fixed assets IFRS | Prior1YearDuration | 56364000 | JPY |
| Loss on sale and retirement of fixed assets IFRS | CurrentYearDuration | 22484000 | JPY |
| Impairment losses on non financial assets pl IFRS | Prior1YearDuration | - | JPY |
| Impairment losses on non financial assets pl IFRS | CurrentYearDuration | 333128000 | JPY |
| Other other expenses IFRS | Prior1YearDuration | 10518000 | JPY |
| Other other expenses IFRS | CurrentYearDuration | 7343000 | JPY |
| Other expenses IFRS | Prior1YearDuration | 66882000 | JPY |
| Other expenses IFRS | CurrentYearDuration | 362957000 | JPY |
| Financial assets measured at amortized cost interest income IFRS | Prior1YearDuration | 661000 | JPY |
| Financial assets measured at amortized cost interest income IFRS | CurrentYearDuration | 15665000 | JPY |
| Equity instruments designated as measured at fair value through other comprehensive income dividend income IFRS | Prior1YearDuration | 25646000 | JPY |
| Equity instruments designated as measured at fair value through other comprehensive income dividend income IFRS | CurrentYearDuration | 4466000 | JPY |
| Financial assets measured at fair value through profit or loss dividend income IFRS | Prior1YearDuration | - | JPY |
| Financial assets measured at fair value through profit or loss dividend income IFRS | CurrentYearDuration | - | JPY |
| Financial assets measured at fair value through profit or loss gain on investments in partnership IFRS | Prior1YearDuration | 10934000 | JPY |
| Financial assets measured at fair value through profit or loss gain on investments in partnership IFRS | CurrentYearDuration | 10434000 | JPY |
| Foreign exchange gain IFRS | Prior1YearDuration | 15549000 | JPY |
| Foreign exchange gain IFRS | CurrentYearDuration | 45462000 | JPY |
| Others financial assets measured at amortized cost IFRS | Prior1YearDuration | - | JPY |
| Others financial assets measured at amortized cost IFRS | CurrentYearDuration | 36000000 | JPY |
| Finance income IFRS | Prior1YearDuration | 52791000 | JPY |
| Finance income IFRS | CurrentYearDuration | 112029000 | JPY |
| Financial liabilities measured at amortized cost interest expenses IFRS | Prior1YearDuration | 21782000 | JPY |
| Financial liabilities measured at amortized cost interest expenses IFRS | CurrentYearDuration | 35949000 | JPY |
| Lease obligations interest expenses IFRS | Prior1YearDuration | 4161000 | JPY |
| Lease obligations interest expenses IFRS | CurrentYearDuration | 7320000 | JPY |
| Financial assets measured at fair value through profit or loss loss on investments in partnership IFRS | Prior1YearDuration | 13400000 | JPY |
| Financial assets measured at fair value through profit or loss loss on investments in partnership IFRS | CurrentYearDuration | 19547000 | JPY |
| Financial assets measured at fair value through profit or loss loss on valuation of investment securities IFRS | Prior1YearDuration | - | JPY |
| Financial assets measured at fair value through profit or loss loss on valuation of investment securities IFRS | CurrentYearDuration | - | JPY |
| Provision of allowance for doubtful accounts finance costs IFRS | Prior1YearDuration | - | JPY |
| Provision of allowance for doubtful accounts finance costs IFRS | CurrentYearDuration | - | JPY |
| Foreign exchange loss IFRS | Prior1YearDuration | - | JPY |
| Foreign exchange loss IFRS | CurrentYearDuration | - | JPY |
| Other finance costs IFRS | Prior1YearDuration | 4137000 | JPY |
| Other finance costs IFRS | CurrentYearDuration | 5950000 | JPY |
| Finance costs IFRS | Prior1YearDuration | 43481000 | JPY |
| Finance costs IFRS | CurrentYearDuration | 68767000 | JPY |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 16471604000 | JPY |
| Cash and deposits | CurrentYearInstant_NonConsolidatedMember | 15701080000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant_NonConsolidatedMember | 3647976000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentYearInstant_NonConsolidatedMember | 3738266000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |